Pratima takes on the role of Country Speaker in addition to her role as GM and MD of Merck Specialties in India
Merck, a leading science and technology company, today announced that Pratima Reddy as their Country Speaker for India. Pratima takes on this role in addition to leading healthcare strategy and operations in India as GM and Managing Director of Merck Specialities India Pvt Ltd. In her current role, Pratima continues to demonstrate focused leadership to drive positive business outcomes through inclusive and strategic thinking and collaborative execution.
“It is an honour for me represent Merck India as its Country Speaker. I am passionately committed to upholding and further building on the Merck brand and fostering strong industry relations within the country. I look forward to collaborating with leaders across the company’s businesses – life science, healthcare and electronics to communicate our purpose, values, and unique offerings to stakeholders. I firmly believe our people are our most valuable asset and a strong & an empowered team is essential to drive innovation, deliver exceptional products or services and exceed customer expectations,” said Pratima Reddy.
Pratima has over 18 years of experience, including over ten years in the pharmaceutical industry. Since joining Merck in October 2013, Pratima has held several significant leadership positions across multiple functions in local and global teams. Prior to taking over as the General Manager of Healthcare India Operations, Pratima was the Regional Franchise Leader (RFL) of the Cardiovascular, Metabolism and Endocrinology (CM&E) franchise in APAC, where she demonstrated exemplary leadership and delivered successful business outcomes.
The company would like to thank its outgoing Country Speaker, Dr Sreenath NS for showing deep commitment to the goals of Merck India, for actively sponsoring the implementation of DE&I initiatives and actively sponsoring and advocating Corporate Social Responsibility (CSR) in India, spearheading various initiatives that have made a significant positive impact on our communities. His unwavering dedication has not only elevated our organization’s reputation but has also allowed him to effectively represent Merck India in external government and quasi-government bodies. Dr Sreenath will continue to head SBS and focus on scaling our Shared Business Services (SBS) to new heights, ensuring it becomes a best-in-class center of excellence.
About Merck
Merck, a leading science and technology company, operates across life science, healthcare and electronics. More than 64,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2022, Merck generated sales of € 22.2 billion in 66 countries.
Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as Millipore Sigma in life science, EMD Serono in healthcare, and EMD Electronics in electronics.
All Merck news releases are distributed by email at the same time they become available on the Merck website. Please go to www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.
